U.S. Markets closed
  • S&P Futures

    3,706.00
    -3.00 (-0.08%)
     
  • Dow Futures

    29,660.00
    -9.00 (-0.03%)
     
  • Nasdaq Futures

    11,368.50
    -8.25 (-0.07%)
     
  • Russell 2000 Futures

    1,685.00
    -1.10 (-0.07%)
     
  • Crude Oil

    79.32
    +0.58 (+0.74%)
     
  • Gold

    1,652.30
    -3.30 (-0.20%)
     
  • Silver

    18.80
    -0.11 (-0.61%)
     
  • EUR/USD

    0.9703
    -0.0135 (-1.3681%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0835
    -0.0419 (-3.7252%)
     
  • USD/JPY

    143.3250
    +0.9900 (+0.6955%)
     
  • BTC-USD

    18,869.02
    -36.72 (-0.19%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.27 (-0.58%)
     

The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium

·1 min read
Toi Management, LLC
Toi Management, LLC

CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for Sub-Capitation/Specialties” panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22 at 9:00am EST.

About The Oncology Institute, Inc.

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Media

The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806

Revive
Michael Petrone
mpetrone@reviveagency.com
(615) 760-4542

Investors

Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com